Peter Breining is new Postdoc in Nykjær Group

Peter Breining has started as postdoctoral researcher in Nykjaer Group from the 1st of September 2018, where he will collaborate with Mads Kjølby and investigate the function of SorCS1 in metabolic disorders with a particular focus on how SorCS1 affects cellular signaling and respiration.

He will take advantage of multiple tools including biochemical assays, CRISPR/Cas9 technology, RNA scope in situ hybridization, and confocal microscopy, and he will use human tissue and mice as model organisms. Peter’s study will lead to better understanding of mechanisms involved in insulin receptor signalling, browning of fat tissue and glucose uptake.